ReviewChemical & biomedical imaging2026
Advanced CRISPR Technologies for RNA Imaging in Live Cells.
Review in Chemical & biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent Advances in the Development of CRISPR-Based Live-Cell Molecular Imaging and Sensing.Molecular imaging and biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNA plays a pivotal role in the regulation of gene expression, and its spatiotemporal dynamics are critical for elucidating fundamental biological processes and disease mechanisms. However, traditional RNA imaging methods, such as fluorescence in situ hybridization (FISH) and the MS2-GFP system, often require cell fixation, suffer from low labeling efficiency, or interfere with native RNA functionthus limiting their ability to monitor RNA behavior in living cells. In recent years, CRISPR technology has rapidly emerged as a powerful tool for live-cell RNA imaging due to its high target specificity, signal amplification capability, and excellent compatibility with living systems. This review provides a comprehensive overview of recent advances in CRISPR-based live-cell RNA imaging, highlighting its imaging principles, technical advantages, and representative applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.